H.R. 3 Lower Drug Costs Now; S. 102 Prescriptions Drug Price Relief Act of 2019
2025 · 4th Quarter (Oct 1 - Dec 31)
AMGEN, INC. FKA HORIZON THERAPEUTICS USA, INC.
Filed by S-3 GROUP.
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 16, 2026
- Income
- $60,000.00
- Expenses
- Not reported
- Registrant
- S-3 GROUP
- Filing UUID
- 5af1f56f-2494-4067-ae2d-cbdf64bac0de
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to health care research
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.